#USA #Dublin #Atreon Orthopedics #Darin Johnson #Autobiologic

Atreon Orthopedics Welcomes Darin Johnson to Board of Directors

Atreon Orthopedics®, Inc. has recently made headlines by appointing Darin Johnson, a respected figure in the healthcare sector, to its Board of Directors. With over two decades of experience in the medical technology industry, Johnson is poised to bring significant expertise and strategic insight to the company as it continues to innovate and expand its offerings.

A Proven Leader in Medical Technology

Johnson's impressive background includes his role as CEO of Exactech, Inc., where he directed the operations of a global orthopedic implant and technology organization with around 900 employees spread across 13 countries. Under his leadership, Exactech experienced substantial growth and successfully scaled its operations within the orthopedics sector.

Ronald Bracken, the current CEO of Atreon Orthopedics, expressed his enthusiasm about Johnson's addition, stating, "Darin is a rare combination of strategist, operator, and passionate people leader. His breadth of experience will be invaluable as Atreon accelerates the commercialization of its Autobiologic™ platform and expands into new surgical indications."

During his tenure at Exactech, Johnson successfully founded and scaled the company's Extremities Business Unit. This division became the largest operating segment of Exactech, notably turning the Equinoxe® shoulder platform from zero sales into a global franchise achieving nearly two decades of double-digit growth across more than twenty countries. His leadership extended beyond this, as he also served as a Board Director for JointMedica Ltd, significantly contributing to the company's FDA Breakthrough Device-designated hip resurfacing technology.

Expanding the Vision for Atreon Orthopedics

In an official statement, Johnson shared his excitement about joining Atreon at a critical time in the company's journey. He highlighted the potential of regenerative synthetics to disrupt significant clinical markets, calling Atreon's Autobiologic matrices a meaningful biologic advancement in tissue remodeling and repair. "I look forward to supporting the team as they expand the platform, deepen clinical evidence, and broaden surgeon adoption," said Johnson.

His career began in investment banking and private equity, which provides him with a robust foundation in capital markets, M&A, and stakeholder engagement. Johnson holds a BA in Business Economics from Brown University, reinforcing his strategic acumen and understanding of economic trends crucial for Atreon's growth.

About Atreon Orthopedics

Founded and headquartered in Dublin, Ohio, Atreon Orthopedics specializes in innovative medical technology, particularly focusing on synthetic healing solutions. Their groundbreaking Autobiologic™ matrices are designed to optimize the biological microenvironment, promote native tissue remodeling, and enhance healing outcomes. Built utilizing advanced electrospun scaffold technology, Atreon offers a consistent and fully synthetic alternative to tissue-derived products for orthopedic and wound care applications.

By adding Darin Johnson to its board, Atreon Orthopedics not only strengthens its leadership but also sets a clear path for growth as it explores new opportunities in the rapidly evolving medical technology landscape. With Johnson aboard, the future looks bright for Atreon as they continue to innovate and deliver on their commitment to quality and efficacy in healthcare.